Financials
Financial year 2025
Apotheek BUYSE from Ichtegem, company number BE0421062350, closed financial year 2025 with a result of € 76,572 after tax. For that financial year Apotheek BUYSE recorded a gross margin of € 156,792 and equity of € 361,744. Compared with financial year 2024, the result moved from € 68,756 to € 76,572. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 361,744
▼ 34% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 76,572
▲ 11% vs 2024
Profit after tax over the fiscal year.
€ 341,774
▲ 44% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 262,022 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 133
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 59,368
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 66,442
▼ 12% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 30,196
▲ 18% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 119,616 | € 155,787 | € 139,540 | € 156,792 | ▲ 12% |
| Profit after taxes | € 79,412 | € 93,658 | € 68,756 | € 76,572 | ▲ 11% |
| Equity | € 534,181 | € 548,439 | € 547,194 | € 361,744 | ▼ 34% |
| Total debts | € 165,386 | € 192,887 | € 186,323 | € 367,561 | ▲ 97% |
| Cash | € 369,981 | € 237,065 | € 237,513 | € 341,774 | ▲ 44% |
| Retained profit | € 459,181 | € 473,439 | € 472,194 | € 286,744 | ▼ 39% |
| Dividend | € 70,000 | € 79,400 | € 70,000 | € 262,022 | ▲ 274% |
| Balance sheet total | € 699,567 | € 741,325 | € 733,518 | € 729,305 | ▼ 1% |
Key figures of Apotheek BUYSE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek BUYSE?
What happened at Apotheek BUYSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 76,572 (▲ 11% vs 2024). Source: NBB ↗
- Patricia Buyse became a director. NBB
- Sabine Buyse became a director. NBB
- New establishment in Ichtegem. KBO
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 79,412 profit in 2022 to € 76,572 profit in 2025.
Paid € 125,335 in corporate taxes since 2022.
Best year ever: 2023, with € 93,658 profit.
Paid out € 481,422 in dividends to the owners in total.
Management
Behind Apotheek BUYSE are Patricia Buyse and Sabine Buyse.
Directors
According to the 2025 annual accounts
Patricia Buyse
Director
since 2014
Sabine Buyse
Director
since 2014
Establishments
Establishment units
Physical locations of this company
Stationsstraat(FEER) 41
8480 Ichtegem
Bevrijdingslaan 154
9000 Gent
Active since 1 January 1981
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0421.062.350
- VAT number
- BE 0421.062.350
- Registered office
- Stationsstraat(FEER) 41, 8480 Ichtegem
- Names & denominations
- Apotheek BUYSE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 December 1980
- Peppol
- Active · Active since 25 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers